Andersson P
Int Arch Allergy Appl Immunol. 1981;64(3):249-58. doi: 10.1159/000232701.
This investigation examines the effect of a booster dose and cyclophosphamide treatment in guinea pigs sensitized according to different sensitization regimens. The results show that guinea pigs sensitized with a high dose of ovalbumin (10 microgram) develop a transient bronchial reactivity. The administration of a booster dose to guinea pigs sensitized according to this regimen does not result in any secondary response. Cyclophosphamide 30 mg/kg given 2 days before the booster injection or the primary sensitization results in a marked increase in bronchial reactivity when challenged with ovalbumin. This increased bronchial reactivity is reflected in the IgE-like antibody titre examined by PCA. Guinea pigs primarily sensitized with a low dose of ovalbumin (0.5 microgram) show no bronchial reactivity when challenged with antigen. However, guinea pigs sensitized according to this regimen and given a booster dose show a marked secondary response when challenged 7 days after the booster injection. An examination of the antibody classes by PCA show that the booster injection causes an increase in the IgG1--and also in the IgE-like antibody production.
本研究考察了加强剂量和环磷酰胺治疗对按照不同致敏方案致敏的豚鼠的影响。结果显示,用高剂量卵清蛋白(10微克)致敏的豚鼠会出现短暂的支气管反应性。按照该方案致敏的豚鼠给予加强剂量不会产生任何二次反应。在加强注射或初次致敏前2天给予30毫克/千克环磷酰胺,在用卵清蛋白激发时会导致支气管反应性显著增加。这种增加的支气管反应性在通过被动皮肤过敏反应(PCA)检测的类IgE抗体滴度中得到体现。用低剂量卵清蛋白(0.5微克)初次致敏的豚鼠在用抗原激发时未表现出支气管反应性。然而,按照该方案致敏并给予加强剂量的豚鼠在加强注射7天后受到激发时会出现显著的二次反应。通过PCA对抗体类别进行检测显示,加强注射会导致IgG1以及类IgE抗体产生增加。